We are live on ! Find out more
SC

Steven Cohen Point72 Asset Management

AUM $90.7B
1-Year Est. Return 77.13%
 

Steven Cohen is the founder of Point72 Asset Management and previously built SAC Capital into one of the industry’s most profitable trading firms. Point72 operates a multi-manager platform combining fundamental long/short equity with systematic and other strategies. Cohen is also a major figure in sports ownership and philanthropy, while remaining one of the most closely followed names in hedge fund trading culture.

This Fund
S&P 500
This Quarter Est. Return
+2.98%
1 Year Est. Return
+77.13%
3 Year Est. Return
+193.52%
5 Year Est. Return
+254.65%
10 Year Est. Return
+1,421.96%
AUM
$17.8B
AUM Growth
-$118M
Cap. Flow
-$252M
Cap. Flow %
-1.42%
Top 10 Hldgs %
16.12%
Holding
1,137
New
342
Increased
213
Reduced
245
Closed
327

Sector Composition

Rank Sector Weight
1 Healthcare 17.44%
2 Consumer Discretionary 11.72%
3 Energy 10.84%
4 Industrials 8.95%
5 Financials 7.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASIX icon
826
AdvanSix
ASIX
$464M
-483,700
Closed -$13.2M
ASPS icon
827
PUT
Altisource Portfolio Solutions
ASPS
$62.6M
-12,500
Closed -$3.68M
AWI icon
828
CALL
Armstrong World Industries
AWI
$7.55B
-25,000
Closed -$1.15M
AZN icon
829
CALL
AstraZeneca
AZN
$257B
-600,000
Closed -$37.4M
AZO icon
830
AutoZone
AZO
$48.3B
-39,332
Closed -$28.4M
BA icon
831
PUT
Boeing
BA
$169B
-50,000
Closed -$8.84M
BALL icon
832
Ball Corp
BALL
$16.8B
-17,600
Closed -$653K
BAX icon
833
Baxter International
BAX
$13.6B
-633,448
Closed -$32.9M
BDX icon
834
Becton Dickinson
BDX
$52.3B
-569,900
Closed -$102M
BIO icon
835
Bio-Rad Laboratories Class A
BIO
$10.2B
-94,100
Closed -$18.8M
BMRN icon
836
BioMarin Pharmaceuticals
BMRN
$12.9B
-364,800
Closed -$32M
BRFS
837
DELISTED
BRF SA
BRFS
-282,104
Closed -$3.46M
BURL icon
838
CALL
Burlington
BURL
$20.6B
-50,000
Closed -$4.87M
BWA icon
839
BorgWarner
BWA
$13.8B
-5,680
Closed -$209K
C icon
840
Citigroup
C
$221B
-433,284
Closed -$26.6M
CC icon
841
CALL
Chemours
CC
$2.4B
-150,000
Closed -$5.78M
CC icon
842
Chemours
CC
$2.4B
-831,405
Closed -$32M
CERS icon
843
Cerus
CERS
$566M
-410,800
Closed -$1.83M
CF icon
844
CF Industries
CF
$19.6B
-36,500
Closed -$1.07M
CHRD icon
845
Chord Energy
CHRD
$8.09B
-39,500
Closed -$432K
CHRW icon
846
C.H. Robinson
CHRW
$16.5B
-50,000
Closed -$3.87M
CL icon
847
PUT
Colgate-Palmolive
CL
$72.6B
-399,300
Closed -$29.2M
CMI icon
848
Cummins
CMI
$80.9B
-90,200
Closed -$13.6M
CNC icon
849
Centene
CNC
$32.1B
-200,000
Closed -$7.13M
COST icon
850
CALL
Costco
COST
$420B
-10,200
Closed -$1.71M

Similar funds

Steven Cohen's Q2 2017 Portfolio in Review

As of Q2 2017, Steven Cohen held 1,137 positions worth $17.8B, down 0.66% from $17.9B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Steven Cohen's Q2 2017 filing shows 342 new, 213 increased, 245 reduced and 327 closed positions. Its largest new stake was Altaba Inc: 2,260,363 shares worth $123M. The largest sale was Meta Platforms (Facebook), an estimated $264M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Energy.

  • Steven Cohen's largest Q2 2017 buy was Altaba Inc: 2,260,363 shares worth $123M.
  • Steven Cohen added most to Biogen in Q2 2017, an estimated $179M increase.
  • Steven Cohen's biggest Q2 2017 reduction was Meta Platforms (Facebook), cutting an estimated $264M.
  • Steven Cohen fully exited Becton Dickinson in Q2 2017, selling an estimated $102M.
  • Steven Cohen's ten largest holdings make up 16% of its $17.8B portfolio in Q2 2017.
  • Steven Cohen opened 342 new positions and closed 327 in Q2 2017.
  • Steven Cohen's portfolio value fell 0.66% quarter-over-quarter to $17.8B.

Based on Point72 Asset Management's 13F filing for Q2 2017, filed 14 Aug 2017.